1. Collste P, Haglund K, Bahr C von (1980) Plasma levels and effects of metoprolol after single and multiple oral doses. Clin Pharmacol Ther 27:441
2. Duff H, Roden D, Brorson L et al (1983) Electrophysiologic actions of high plasma concentrations of propranolol in human subjects. J Am Coll Cardiol 2:1134
3. Eichelbaum M (1982) Defective oxidation of drugs: Pharmacokinetic and therapeutic implications. Clin Phar-macokin 7:122
4. Eichelbaum M, Echizen H, Vogelsang B (1986) Einfluß der Applikationsart auf die Plasmakonzentrations-Wirkungs-Be-ziehung von Pharmaka. In: Frölich JC (Hrsg) Plasmaspiegel-Wirkungs-Beziehung von Pharmaka. Gustav Fischer Verlag, Stuttgart New York, pp 7
5. Eichelbaum M, Gross AS (1992) The genetic polymorphism of debrisoquine/sparteine metabolism — clinical aspects. In: Kalow W (ed) Pharmacogenetics of drug metabolism. Pergamon Press, New York, pp 625